The adult brain may undergo significant changes around the age of 50, as research suggests a decline in protective immune cells is accompanied by an increase in inflammatory cells, potentially raising the risk for neurodegenerative diseases like dementia. A study analyzing postmortem brain tissue found that after this age, the brain's resident immune cells, known as microglia, appear to be increasingly replaced by immune cells that enter from the bloodstream.
Microglia typically serve to protect the brain by clearing debris and responding to injury. However, the incoming blood-derived cells carry stronger inflammatory signals, according to first author Nathan Zemke, a principal investigator at the UC San Diego Center for Epigenomics. This shift may contribute to the chronic inflammation often linked to cognitive decline and neurodegenerative conditions such as Alzheimer's disease.
Researchers also observed the deterioration of cells responsible for maintaining the blood-brain barrier, a crucial filter that prevents harmful substances from entering the brain. Widespread changes in DNA and gene activity were also noted.
The study, which analyzed tissue from the hippocampus—a region vital for learning and memory—from 40 neurologically healthy adults aged 20 to 95, suggests these midlife brain alterations could explain the increased incidence of neuroinflammation and neurodegenerative diseases with aging.
One promising implication of the findings is that the incoming immune cells originate in the blood, making them potentially more accessible for therapeutic intervention than cells already within the brain. This could open new avenues for treating Alzheimer's and other neurological diseases by modifying blood-derived immune cells to be more protective and less inflammatory when in the brain, rather than directly manipulating cells within the central nervous system.
While these discoveries are in their early stages, understanding why this immune cell replacement occurs and why it varies among individuals could lead to novel strategies for maintaining brain health throughout aging. The researchers cautioned, however, that the study's primary limitation is its reliance on postmortem tissue from different individuals, which allows for the identification of age-related patterns but cannot directly demonstrate how a single person's brain changes over time or definitively prove that specific cellular changes cause cognitive decline.
Further research is needed to determine what triggers the influx of blood-derived immune cells into the brain, investigating factors such as changes in the blood-brain barrier, inflammation, genetics, or lifestyle. The timing and extent of these brain changes also varied considerably among individuals, suggesting that brain aging is not a uniform process.
The study, funded by the National Institutes of Health, was published in the journal Science. The researchers emphasized that the findings are primarily for understanding the biology of brain aging and identifying new research directions, and not for immediate specific medical or lifestyle changes.